Agios Pharmaceuticals, Inc. Q2 FY2026 Earnings Call

Agios Pharmaceuticals, Inc. (AGIO)

Earnings Call FY2026 Q2 Call date: 2026-07-30 Concluded

Quarter scorecard

Revenue

$44.74M

+259.3% YoY

Diluted EPS

$-1.69

Net income

-$100.70M